alirocumab

The drug company, Regeneron, which specializes in biologicals (drugs made utilizing biological systems, such as antibodies, rather than synthesized chemicals), released results of a late-stage trial of their new man-made antibody, alirocumab. (Hopefully the brand name will roll off the tongue with a bit more fluidity).